These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6150581)

  • 21. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
    Schaumann W; Besenfelder E; Boehm E; Neubert P; Roesch A; Sterz H
    Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA; Wiernas TK; Griffin BW; Davis TL
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the histamine H2-receptor in brain: the interaction with LSD.
    Green JP; Weinstein H; Maayani S
    NIDA Res Monogr; 1978; (22):38-59. PubMed ID: 30911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation by histamine of cyclic nucleotide levels in sympathetic ganglia.
    Study RE; Greengard P
    J Pharmacol Exp Ther; 1978 Dec; 207(3):767-78. PubMed ID: 32382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man.
    van Hecken AM; Tjandramaga TB; Mullie A; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):195-200. PubMed ID: 6125204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Icotidine, an antagonist of histamine at both H1 and H2 receptors.
    Ganellin CR; Blakemore RC; Brown TH; Cooper DG; Durant GJ; Harvey CA; Ife RJ; Owen DA; Parsons ME; Rasmussen AC
    N Engl Reg Allergy Proc; 1986; 7(2):126-33. PubMed ID: 2886901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
    McNeil JJ; Mihaly GW; Anderson A; Marshall AW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1981 Sep; 12(3):411-5. PubMed ID: 6117305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermal toxicity and penetration studies following topical application of three histamine H2-receptor antagonists with a comparison with an H1-receptor antagonist.
    Sutton TJ
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):459-65. PubMed ID: 42169
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.
    Jönsson KA; Bodemar G; Gotthard R; Norlander B; Walan A
    Eur J Clin Pharmacol; 1983; 24(3):353-6. PubMed ID: 6134622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatography of histamine H1- and H2-receptor blockers in biosamples.
    Maurer HH
    J Chromatogr; 1990 Oct; 531():369-405. PubMed ID: 1979562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The assay of a novel histamine H2-receptor antagonist, SK&F 93479, in human plasma by normal-phase high-performance liquid chromatography.
    McDowall RD; Lee RM
    J Chromatogr; 1983 Jul; 275(2):377-85. PubMed ID: 6137490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enantioselective pharmacokinetics of homochlorcyclizine. II: Disposition and metabolism of (+)-, (-)- and racemic homochlorcyclizine after oral administration to man.
    Nishikata M; Nomura A; Iseki K; Miyazaki K; Nakai A; Fushida H; Miyake K; Arita T
    Eur J Clin Pharmacol; 1992; 43(5):533-8. PubMed ID: 1362384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of antihistamines with lipid bilayers.
    Rooney EK; Gore MG; Lee AG
    Biochem Pharmacol; 1979 Jul; 28(14):2199-205. PubMed ID: 40556
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism of brompheniramine.
    Bruce RB; Turnbull LB; Newman JH; Pitts JE
    J Med Chem; 1968 Sep; 11(5):1031-4. PubMed ID: 4386938
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein binding properties of some histamine H2 antagonists: a 1H nuclear magnetic resonance study of antihistamine-calmodulin interactions.
    Reid DG
    Biochim Biophys Acta; 1986 Apr; 886(1):18-25. PubMed ID: 2869789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temelastine, a novel histamine H1-receptor antagonist, does not induce oxidative hepatic enzyme activity in man.
    de Mey C; Meineke I; Wesche H
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):65-9. PubMed ID: 2886338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gastrointestinal absorption of PRD-92 Ea, a new anti-allergy drug.
    Johnson AJ; Beets JL
    Br J Clin Pharmacol; 1979 May; 7(5):511-3. PubMed ID: 38823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of pheniramine and its N-demthylated metabolites in man--comparison with chlorpheniramine and brompheniramine data.
    Kabasakalian P; Taggart M; Townley E
    J Pharm Sci; 1968 Apr; 57(4):621-3. PubMed ID: 4385103
    [No Abstract]   [Full Text] [Related]  

  • 40. The metabolism and excretion of cinnarizine by rats.
    Soudijn W; Van Wijngaarden I
    Life Sci; 1968 Mar; 7(5):231-8. PubMed ID: 4384440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.